| CAS | Product Name | MF |
|
2133460-43-0
|
(3S,5R,6R)-Bupropion Impurity
|
C12H14ClNO3S
|
|
556796-88-4
|
Macitentan IMpurity
|
C17H15Br2N5O4S
|
|
2689-70-5
|
Methyl 2-Methyl-3-Oxo-Tetrahydrothiophene-2-Carbonate
|
C7H10O3S
|
|
875755-24-1
|
NS8593 HYDROCHLORIDE
|
C17H17N3.ClH
|
|
1051487-82-1
|
(±)-(3R*,4S*)-2-Oxo-4-phenyl-3-pyrollidinecarboxylicacid2-[1-(3-bromophenyl)ethylidene]hydrazide
|
C19H18BrN3O2
|
|
1107650-56-5
|
MORPHOLINE-2,2,3,3,5,5,6,6-D8 HYDROCHLORIDE
|
C4H2ClD8NO
|
|
37686-68-3
|
2-Fluoro-3,4-dimethoxy-benzaldehyde
|
C9H9FO3
|
|
1869069-71-5
|
Iopamidol EP impurity F
|
C16H20I3N3O6
|
|
75281-25-3
|
KGUMXGDKXYTTEY-FAOQNJJDSA-N
|
C20H28O3
|
|
930-52-9
|
2-Ethyl-2-imidazoline
|
C5H10N2
|
|
87842-32-8
|
POLY(TRIMETHYLSILYL)PROPYNE
|
C7H16Si
|
|
132682-23-6
|
2-Oxazolidinone, 4-(hydroxyMethyl)-, (4R)-
|
C4H7NO3
|
|
723308-58-5
|
(3R,4R)-4-Amino-3-methyl-piperidine-1-carboxylic acid tert-butyl ester
|
C11H22N2O2
|
|
124774-48-7
|
Ampicillin Impurity F
|
C15H21N3O3S
|
|
81483-91-2
|
ACETYL-(D-LYS89,SAR90)-BETA-LIPOTROPIN (88-91) (HUMAN)
|
C22H40N6O8
|
|
947533-11-1
|
2-(Difluoromethoxy)-benzeneboronic acid
|
C7H7BF2O3
|
|
1246815-36-0
|
Nimodipine-d7
|
C21H26N2O7
|
|
1037138-94-5
|
2-bromo-4-fluoro-N-methylaniline
|
C7H7BrFN
|
|
37839-63-7
|
germacrene D
|
C15H24
|
|
1244022-52-3
|
Tenofovir Related Compound 14
|
C8H11N5O
|
|
938185-06-9
|
Erlotinib
|
C16H11N3O2
|
|
1192750-33-6
|
PE 154
|
C35H35N5O4
|
|
148029-26-9
|
(Des-Gly10,D-Ala6,Pro-NHEt9)-LHRH
|
C56H78N16O12
|
|
1112209-40-1
|
2-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde
|
C13H16BFO3
|
|
100937-76-6
|
2H-Pyran-3-ol, tetrahydro-, (R)-
|
C5H10O2
|
|
50841-46-8
|
ethyl 3,5-bis(benzyloxy)benzoate
|
C23H22O4
|
|
1601496-05-2
|
3-(1,3-benzothiazol-5-yl)-7-(1,3-dimethyl-1H-pyrazol-5-yl)thieno[3,2-c]pyridin-4-amine
|
C19H15N5S2
|
|
1330061-67-0
|
CAIX Inhibitor S4
|
C15H17N3O4S
|
|
1443680-94-1
|
2-bromo-9,9-dimethyl-9,10-dihydroacridine
|
C15H14BrN
|
|
2203740-23-0
|
8-Methoxy Entecavir
|
C13H17N5O4
|
|
34058-51-0
|
2-Methyl-1H-indole-4-carboxylic acid Methyl ester
|
C11H11NO2
|
|
58476-59-8
|
N-(4-broMophenyl)-2-nitrobenzenaMine
|
C12H9BrN2O2
|
|
1363382-11-9
|
Carbamic acid, N-[3-(hydroxymethyl)-3-oxetanyl]-, 1,1-dimethylethyl ester
|
C9H17NO4
|
|
52603-48-2
|
2-amino-3,5-Dicyanoacetophenone
|
C7H5N3S
|
|
5137-45-1
|
ETHYLENE GLYCOL ETHYL METHYL ETHER
|
C5H12O2
|
|
4805-70-3
|
3-BROMO-2-METHYLIMIDAZO[1,2-A]PYRIDINE
|
C8H7BrN2
|
|
942070-84-0
|
5-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-oxazole
|
C9H14BNO3
|
|
80141-93-1
|
Benzeneacetonitrile, 4-fluoro-2-methyl- (9CI)
|
C9H8FN
|
|
133261-83-3
|
(R)-2-METHYL-CBS-OXAZABOROLIDINE
|
C18H20BNO
|
|
1116681-99-2
|
2,3-Difluoro-4-methylphenylboronic acid pinacol ester
|
C13H17BF2O2
|
|
153165-72-1
|
(R)-Tetrahydro-2-furancarbothioic acid
|
C5H8O2S
|
|
148356-06-3
|
4-(2-Aminoethyl)cyclohexanol (cis- and trans- mixture)
|
C8H17NO
|
|
545882-60-8
|
5,8-Dioxaspiro[3.4]octane-2-Methanol
|
C7H12O3
|
|
191529-08-5
|
1,3,5-Benzenetrimethanol, 2,4,6-tribromo-
|
C9H9Br3O3
|
|
1614253-96-1
|
4,9-Dibromo-2,7-bis(2-butyloctyl)benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetraone
|
C38H52Br2N2O4
|
|
220904-99-4
|
-5-chloro-3-(3,5-dibromo-4-hydroxybenzylidene)indolin-2-one
|
C15H8Br2ClNO2
|
|
224323-51-7
|
(3-fluoro-4-(Morpholinyl)phenyl)isocyanate
|
C11H11FN2O2
|
|
1196146-81-2
|
1-BROMO-6-CHLORO-ISOQUINOLINE
|
C9H5BrClN
|
|
91247-06-2
|
5,6-DIMETHOXY-INDAN-1-YLAMINE
|
C11H15NO2
|
|
1145671-52-8
|
6,7-bis(2-methoxyethoxy)-N-phenylquinazolin-4-amine
|
C20H23N3O4
|
|
45849-05-6
|
Bicyclo[2.2.1]heptane-2,3-dimethanol
|
C9H16O2
|
|
14663-53-7
|
(4-OXO-4H-QUINAZOLIN-3-YL)-ACETIC ACID
|
C10H8N2O3
|
|
27584-70-9
|
(3H)-OXAZOLONE)
|
C3H3NO2
|
|
121284-21-7
|
H-LYS-ARG-THR-LEU-ARG-ARG-OH
|
C34H68N16O8
|
|
1144516-21-1
|
4-[[3-Chloro-4-(2-pyridinylmethoxy)phenyl]amino]-7-ethoxy-6-[(1-methyl-2-pyrrolidinylidene)amino]-3-quinolinecarbonitrile
|
C29H27ClN6O2
|
|
55405-68-0
|
3,6-Dibromopyrazolo[1,5-a]pyrimidine
|
C6H3Br2N3
|
|
2044706-58-1
|
Fasudil Impurity 6
|
C11H11NO3S
|
|
123135-05-7
|
Uncaric acid
|
C30H48O5
|
|
103404-59-7
|
H-LYS-VAL-ILE-LEU-PHE-OH ACETATE SALT
|
C32H54N6O6
|
|
871254-63-6
|
6-Chloro-3-methyl-1H-pyrazolo[3,4-d]pyrimidine
|
C6H5ClN4
|
|
269730-62-3
|
FMOC-CYS(T-BUTYLCARBOXYMETHYL)-OH
|
C24H27NO6S
|
|
124635-86-5
|
Flurbiprofen Impurity 6
|
C18H19FO4
|
|
3976-29-2
|
2-PROPANOL-1,1,1,3,3,3-D6
|
C3H2D6O
|
|
160662-16-8
|
(LYS9,TRP11,GLU12)-NEUROTENSIN (8-13) (CYCLIC ANALOG)
|
C39H59N11O8
|
|
20587-61-5
|
2-(2-hydroxyethoxy)ethyl benzoate
|
C11H14O4
|
|
2113650-04-5
|
BMS-1001
|
C35H35ClN2O7
|
|
1534369-41-9
|
2-Fluoro-6-hydroxybenzeneboronic acid pinacol ester
|
C12H16BFO3
|
|
1562777-29-0
|
Benzoic acid, 4,4'-(9,10-anthracenediyldi-2,1-ethynediyl)bis-
|
C32H18O4
|
|
39672-77-0
|
9±-Bromodesonide
|
C24H31BrO6
|
|
1365970-48-4
|
(33R,35S,91R,92R,5S,E)-5-(tert-butyl)-14,14-difluoro-4,7-dioxo-2,8,10-trioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopentanacyclotetradecaphan-12-ene-35-carboxylic acid
|
C29H34F2N4O7
|
|
99980-20-8
|
2-Piperidinecarboxylic acid, 5-oxo-, hydrochloride
|
C6H10ClNO3
|
|
19327-38-9
|
C8E3
|
C14H30O4
|
|
883731-58-6
|
4-(TrifluoroMethyl)cyclohexaneMethanol (cis- and trans- Mixture)
|
C8H13F3O
|
|
65929-03-5
|
FOR-MET-LEU-PHE-OME
|
C22H33N3O5S
|
|
768350-18-1
|
5,7,4'-TRIHYDROXY-6-METHOXYISOFLAVONE
|
C16H12O6
|
|
43217-31-8
|
9 10-DI-P-TOLYLANTHRACENE
|
C28H22
|
|
680217-71-4
|
ETHYL 2-(2,6-DIFLUOROPHENYL)ACETATE
|
C10H10F2O2
|
|
58536-48-4
|
(2-METHYL-2H-INDAZOL-3-YL)METHANOL
|
C9H10N2O
|
|
65338-28-5
|
Cyclobutanecarboxylic acid, 1-Methyl-, ethyl ester
|
C8H14O2
|
|
607371-01-7
|
3-bromo-N-ethyl-5-nitropyridin-4-amine
|
C7H8BrN3O2
|
|
16630-60-7
|
3-(methylthio)propyl butyrate
|
C8H16O2S
|
|
871269-13-5
|
4-(3-BROMOPHENYLSULFONYL)MORPHOLINE
|
C10H12BrNO3S
|
|
1174038-59-5
|
tert-butyl 3-iodo-1H-pyrrolo[2,3-c]pyridine-1-carboxylate
|
C12H13IN2O2
|
|
1799280-05-9
|
TaMsulosin EP IMpurity D
|
C19H26N2O5S
|
|
18800-76-5
|
BOC-D-GLU(OBZL)-OSU
|
C21H26N2O8
|
|
1691715-12-4
|
3-chloro-5-methoxyisoquinoline
|
C10H8ClNO
|
|
2896-20-0
|
H-ARG-VAL-OH ACETATE SALT
|
C11H23N5O3
|
|
2271358-65-5
|
UAMC-3203 hydrochloride
|
C25H38ClN5O2S
|
|
1639298-89-7
|
4-Chloro-2-fluoro-5-nitro-benzaldehyde
|
C7H3ClFNO3
|
|
125310-04-5
|
Glycyroside
|
C27H30O13
|
|
850589-48-9
|
3-CHLORO-4-(N,N-DIETHYLCARBAMOYL)PHENYLBORONIC ACID
|
C11H15BClNO3
|
|
112748-19-3
|
scyliorhinin II
|
C77H119N21O26S3
|
|
115955-48-1
|
3-(DIMETHYLAMINO)-1-(3-NITROPHENYL)-2-PROPEN-1-ONE
|
C11H12N2O3
|
|
1016529-46-6
|
2-(2,6-difluorophenyl)pyrrolidine
|
C10H11F2N
|
|
1313279-48-9
|
2-[trans-4-aminocyclohexyl]acetonitrile hydrochloride
|
C8H15ClN2
|
|
2452301-27-6
|
Empagliflozin Impurity 17
|
C23H28O7
|
|
131880-55-2
|
2,2-DIMETHYL-6-CHROMANESULFONYL CHLORIDE
|
C11H13ClO3S
|
|
144912-84-5
|
N-BOC-1,3-DIAMINO-2-PROPANOL
|
C8H18N2O3
|
|
868046-56-4
|
[1,1':3',1'':3'',1'''-Quaterphenyl]-4,4'''-dicarboxylic acid, 5',5''-bis(4-carboxyphenyl)-2',2'',4',4'',6',6''-hexamethyl- (9CI)
|
C46H38O8
|
|
5687-78-5
|
3-cyclopropylprop-2-enoic acid
|
C6H8O2
|